{"id":23609,"date":"2000-02-21T12:51:17","date_gmt":"2000-02-21T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23609"},"modified":"2018-04-14T01:59:05","modified_gmt":"2018-04-14T06:59:05","slug":"23609","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/ja\/23609\/","title":{"rendered":"2000 \u5e74 2 \u6708 21 \u65e5\u306e\u52d5\u7269\u5065\u5eb7\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8 \u2013 \u7279\u5225\u7248"},"content":{"rendered":"<p>SPECIAL EDITION<br \/>\nBrakke Consulting&rsquo;s <br \/>\nAnimal Health News &amp; Notes for February 21, 2000<br \/>\nCopyright &copy; Brakke Consulting, Inc.<\/p>\n<p>(note: the regular edition of Brakke Consulting Animal Health News &amp; Notes will be published on February 25.)<\/p>\n<p>Company News Releases<br \/>\n&bull;&nbsp;Merck and Aventis, joint parent companies of Merial, announced that effective February 21, 2000, Alan Reade will assume the position of executive chairman of Merial.&nbsp; The announcement was made on February 18, 2000.&nbsp; Reade was formerly the president and CEO of Rhone-Poulenc Agro for North American Operations, and is currently the leader of the Aventis CropScience post-merger integration process.&nbsp; In order to ensure a smooth transition John Preston, the previous executive chairman of Merial, and Louis Champel, the previous CEO, will serve as consultants to Merial and Alan Reade for a limited period of time.<\/p>\n<p>*********************************************************************<\/p>\n<p>Brakke Consulting Viewpoint<\/p>\n<p>Merck and Rhone Poulenc announced last week that they have completed the first phase of the Merial organization that was developed with the forming of Merial in 1997.&nbsp; A press release was made by Merial in London on February 18, 2000 indicating that Alan Reade would become the Executive Chairman of Merial effective February 21, 2000.&nbsp; The release further indicates that Dr. Preston and Mr. Champel will serve as consultants to Merial and Mr. Reade for a limited period of time.<\/p>\n<p>The timing and content of this announcement apparently caught many Merial employees and the industry by surprise.&nbsp; It had been assumed and anticipated that Louis Champel would become the Executive Chairman and that Dr. Preston would return to Merck at the end of the first two years.&nbsp; It is not clear what the underlying implications are for this abrupt change.&nbsp; We will be watching closely to see how this change affects Merial and others in the industry.<\/p>\n<p>[Ron Brakke]<\/p>\n<p>********************************************************<br \/>\nThis electronic newsletter is the sole property of Brakke Consulting, Inc.<br \/>\nAny use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.<\/p>\n<p>For more information about Brakke Consulting&rsquo;s services and syndicated studies, visit our website at <a href=\"https:\/\/brakkeconsulting.com\">www.brakkeconsulting.com<\/a> &lt;<a href=\"https:\/\/brakkeconsulting.com\">https:\/\/brakkeconsulting.com<\/a>&gt;.<\/p>\n<p>If this email was forwarded to you and you would like to be added to the circulation list, please send an email to <a href=\"mailto:info@brakkeconsulting.com\">info@brakkeconsulting.com<\/a> with &ldquo;add&rdquo; typed in the subject line, and your name and company affiliation in the body of the message, and you will be added to the mailing list.&nbsp; If you would like for us to remove your name from the circulation list, please send an email to <a href=\"mailto:info@brakkeconsulting.com\">info@brakkeconsulting.com<\/a> with &ldquo;remove&rdquo; and your name typed in the subject line.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u7279\u5225\u7248 Brakke Consulting \u306e 2000 \u5e74 2 \u6708 21 \u65e5\u306e Animal Health News &amp; Notes Copyright \u00a9 Brakke Consulting, Inc. (\u6ce8: Brakke Consulting \u306e Animal Health News &amp; Notes \u306e\u901a\u5e38\u7248\u306f 2 \u6708 25 \u65e5\u306b\u767a\u884c\u3055\u308c\u307e\u3059\u3002) \u4f01\u696d\u30cb\u30e5\u30fc\u30b9\u30ea\u30ea\u30fc\u30b9 \u2022 Merck \u3068 Aventis \u306f\u3001Merial \u306e\u5171\u540c\u89aa\u4f1a\u793e\u3067\u3042\u308a\u30012000 \u5e74 2 \u6708 21 \u65e5\u4ed8\u3051\u3067 Alan Reade \u304c Merial \u306e\u4f1a\u9577\u306b\u5c31\u4efb\u3059\u308b\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u767a\u8868\u306f 2000 \u5e74 2 \u6708 18 \u65e5\u306b\u884c\u308f\u308c\u307e\u3057\u305f\u3002Reade \u306f\u4ee5\u524d\u3001Rhone-Poulenc Agro \u306e\u5317\u7c73\u4e8b\u696d\u62c5\u5f53\u793e\u9577\u517c CEO \u3092\u52d9\u3081\u3066\u304a\u308a\u3001\u73fe\u5728\u306f Aventis CropScience \u306e\u5408\u4f75\u5f8c\u306e\u7d71\u5408\u30d7\u30ed\u30bb\u30b9\u3092\u4e3b\u5c0e\u3057\u3066\u3044\u307e\u3059\u3002\u5186\u6ed1\u306a\u79fb\u884c\u3092\u78ba\u5b9f\u306b\u3059\u308b\u305f\u3081\u3001Merial \u306e\u524d\u4f1a\u9577 John Preston \u3068\u524d CEO Louis Champel \u304c\u4e00\u5b9a\u671f\u9593\u3001Merial \u3068 Alan Reade \u306e\u30b3\u30f3\u30b5\u30eb\u30bf\u30f3\u30c8\u3092\u52d9\u3081\u307e\u3059\u3002 ************************************************************************* Brakke Consulting Viewpoint Merck\u3068Rhone Poulenc\u306f\u5148\u9031\u30011997\u5e74\u306e\u30e1\u30ea\u30a2\u30eb\u8a2d\u7acb\u3068\u3068\u3082\u306b\u958b\u767a\u3055\u308c\u305f\u30e1\u30ea\u30a2\u30eb\u7d44\u7e54\u306e\u7b2c1\u30d5\u30a7\u30fc\u30ba\u3092\u5b8c\u4e86\u3057\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u30022000\u5e742\u670818\u65e5\u306b\u30ed\u30f3\u30c9\u30f3\u3067\u30e1\u30ea\u30a2\u30eb\u304b\u3089\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\u304c\u767a\u8868\u3055\u308c\u3001\u30a2\u30e9\u30f3\u30fb\u30ea\u30fc\u30c9\u304c2000\u5e742\u670821\u65e5\u4ed8\u3051\u3067\u30e1\u30ea\u30a2\u30eb\u306e\u4f1a\u9577\u306b\u5c31\u4efb\u3059\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u307e\u3057\u305f\u3002\u3053\u306e\u30ea\u30ea\u30fc\u30b9\u3067\u306f\u3055\u3089\u306b\u3001\u30d7\u30ec\u30b9\u30c8\u30f3\u535a\u58eb\u3068\u30b7\u30e3\u30f3\u30da\u30eb\u6c0f\u304c\u9650\u3089\u308c\u305f\u671f\u9593\u3001\u30e1\u30ea\u30a2\u30eb\u3068\u30ea\u30fc\u30c9\u6c0f\u306e\u30b3\u30f3\u30b5\u30eb\u30bf\u30f3\u30c8\u3068\u3057\u3066\u50cd\u304f\u3053\u3068\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/23609\/\" class=\"view-full-post-btn\">\u5168\u6587\u3092\u898b\u308b<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23609","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/ja\/23609\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"SPECIAL EDITION Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 21, 2000 Copyright &copy; Brakke Consulting, Inc. (note: the regular edition of Brakke Consulting Animal Health News &amp; Notes will be published on February 25.) Company News Releases &bull;&nbsp;Merck and Aventis, joint parent companies of Merial, announced that effective February 21, 2000, Alan Reade will assume the position of executive chairman of Merial.&nbsp; The announcement was made on February 18, 2000.&nbsp; Reade was formerly the president and CEO of Rhone-Poulenc Agro for North American Operations, and is currently the leader of the Aventis CropScience post-merger integration process.&nbsp; In order to ensure a smooth transition John Preston, the previous executive chairman of Merial, and Louis Champel, the previous CEO, will serve as consultants to Merial and Alan Reade for a limited period of time. ********************************************************************* Brakke Consulting Viewpoint Merck and Rhone Poulenc announced last week that they have completed the first phase of the Merial organization that was developed with the forming of Merial in 1997.&nbsp; A press release was made by Merial in London on February 18, 2000 indicating that Alan Reade would become the Executive Chairman of Merial effective February 21, 2000.&nbsp; The release further indicates that Dr. Preston and Mr. Champel will serve as consultants to Merial and Mr. Reade for a limited period of time. TheView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/ja\/23609\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2000-02-21T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T06:59:05+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for February 21, 2000 &#8211; Special Edition\",\"datePublished\":\"2000-02-21T18:51:17+00:00\",\"dateModified\":\"2018-04-14T06:59:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/\"},\"wordCount\":450,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/\",\"url\":\"https:\/\/brakkeconsulting.com\/23609\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2000-02-21T18:51:17+00:00\",\"dateModified\":\"2018-04-14T06:59:05+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/23609\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/23609\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for February 21, 2000 &#8211; Special Edition\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brakke Consulting\u304b\u3089\u306e\u30cb\u30e5\u30fc\u30b9","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/ja\/23609\/","og_locale":"ja_JP","og_type":"article","og_title":"News from Brakke Consulting","og_description":"SPECIAL EDITION Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 21, 2000 Copyright &copy; Brakke Consulting, Inc. (note: the regular edition of Brakke Consulting Animal Health News &amp; Notes will be published on February 25.) Company News Releases &bull;&nbsp;Merck and Aventis, joint parent companies of Merial, announced that effective February 21, 2000, Alan Reade will assume the position of executive chairman of Merial.&nbsp; The announcement was made on February 18, 2000.&nbsp; Reade was formerly the president and CEO of Rhone-Poulenc Agro for North American Operations, and is currently the leader of the Aventis CropScience post-merger integration process.&nbsp; In order to ensure a smooth transition John Preston, the previous executive chairman of Merial, and Louis Champel, the previous CEO, will serve as consultants to Merial and Alan Reade for a limited period of time. ********************************************************************* Brakke Consulting Viewpoint Merck and Rhone Poulenc announced last week that they have completed the first phase of the Merial organization that was developed with the forming of Merial in 1997.&nbsp; A press release was made by Merial in London on February 18, 2000 indicating that Alan Reade would become the Executive Chairman of Merial effective February 21, 2000.&nbsp; The release further indicates that Dr. Preston and Mr. Champel will serve as consultants to Merial and Mr. Reade for a limited period of time. TheView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/ja\/23609\/","og_site_name":"Brakke Consulting Website","article_published_time":"2000-02-21T18:51:17+00:00","article_modified_time":"2018-04-14T06:59:05+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"Brakke Consulting","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/23609\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/23609\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for February 21, 2000 &#8211; Special Edition","datePublished":"2000-02-21T18:51:17+00:00","dateModified":"2018-04-14T06:59:05+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/23609\/"},"wordCount":450,"articleSection":["Newsletter"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/23609\/","url":"https:\/\/brakkeconsulting.com\/23609\/","name":"Brakke Consulting\u304b\u3089\u306e\u30cb\u30e5\u30fc\u30b9","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2000-02-21T18:51:17+00:00","dateModified":"2018-04-14T06:59:05+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/23609\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/23609\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/23609\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for February 21, 2000 &#8211; Special Edition"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"\u30d6\u30e9\u30c3\u30b1\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0","url":"https:\/\/brakkeconsulting.com\/ja\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/posts\/23609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/comments?post=23609"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/posts\/23609\/revisions"}],"predecessor-version":[{"id":25078,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/posts\/23609\/revisions\/25078"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/media?parent=23609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/categories?post=23609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/ja\/wp-json\/wp\/v2\/tags?post=23609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}